Ravi Thippeswamy

Bengaluru, KA, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Optimizing genomics-aware clinical agents in precision oncology.

Optimizing genomics-aware clinical agents in precision oncology.

Journal: NPJ systems biology and applications

Published: October 24, 2025

Real-World Evidence of the Impact of CanAssist Breast on Physician's Decision About the Use of Adjuvant Chemotherapy in Early Breast Cancer.

Real-World Evidence of the Impact of CanAssist Breast on Physician's Decision About the Use of Adjuvant Chemotherapy in Early Breast Cancer.

Journal: Cureus

Published: December 12, 2024

Real world study of safety and efficacy of lorlatinib as second line and beyond in ALK-rearranged advanced non-small cell lung cancer patients in India - a multicentre chart review study (ROSELAND).

Real world study of safety and efficacy of lorlatinib as second line and beyond in ALK-rearranged advanced non-small cell lung cancer patients in India - a multicentre chart review study (ROSELAND).

Journal: Ecancermedicalscience

Published: August 28, 2023

Ramucirumab in Indian Patients with Advanced Gastric Cancer-Does Borderline Performance Status and Heavy Burden of Disease in Real World Practice Impact Clinical Benefit?

Ramucirumab in Indian Patients with Advanced Gastric Cancer-Does Borderline Performance Status and Heavy Burden of Disease in Real World Practice Impact Clinical Benefit?

Journal: South Asian journal of cancer

Published: July 14, 2022

Practice patterns and outcomes with the use of regorafenib in metastatic colorectal cancer: Results from the Regorafenib in Metastatic colorectal cancer - An Indian exploratory analysis study.

Practice patterns and outcomes with the use of regorafenib in metastatic colorectal cancer: Results from the Regorafenib in Metastatic colorectal cancer - An Indian exploratory analysis study.

Journal: South Asian journal of cancer

Published: February 16, 2019

Lomustine, cytarabine, cyclophosphamide, etoposide - An effective conditioning regimen in autologous hematopoietic stem cell transplant for primary refractory or relapsed lymphoma: Analysis of toxicity, long-term outcome, and prognostic factors.

Lomustine, cytarabine, cyclophosphamide, etoposide - An effective conditioning regimen in autologous hematopoietic stem cell transplant for primary refractory or relapsed lymphoma: Analysis of toxicity, long-term outcome, and prognostic factors.

Journal: Journal of cancer research and therapeutics

Published: September 11, 2018

Outcomes in lung cancer: An experience from routine tertiary care setting.

Outcomes in lung cancer: An experience from routine tertiary care setting.

Journal: Indian journal of cancer

Published: December 05, 2017

Eribulin mesylate in Indian patients: A single center experience.

Eribulin mesylate in Indian patients: A single center experience.

Journal: Indian journal of cancer

Published: February 25, 2016

LACE versus BEAM conditioning in relapsed and refractory lymphoma transplant: retrospective multicenter analysis of toxicity and efficacy.

LACE versus BEAM conditioning in relapsed and refractory lymphoma transplant: retrospective multicenter analysis of toxicity and efficacy.

Journal: International journal of hematology

Published: June 07, 2015

Stage IV lung cancer: Is cure possible?

Stage IV lung cancer: Is cure possible?

Journal: Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology

Published: September 20, 2013

Biochemical characterization of C4 protein of Cotton leaf curl Kokhran Virus-Dabawali.

Biochemical characterization of C4 protein of Cotton leaf curl Kokhran Virus-Dabawali.

Journal: Biochimica et biophysica acta

Published: September 12, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026